z-logo
open-access-imgOpen Access
Sperm-zona pellucida interaction and immunological infertility
Author(s) -
Masao Kamada,
Masahiko Murakami,
T Daitoh,
K. Mori,
Shozo Yamamoto,
Koji Nakagawa,
Shuji Yamano,
Minoru Irahara,
Toshihiro Aono,
Takahide Mori
Publication year - 2006
Publication title -
reproductive medicine and biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.005
H-Index - 22
eISSN - 1447-0578
pISSN - 1445-5781
DOI - 10.1007/bf03016145
Subject(s) - zona pellucida , sperm , acrosome reaction , capacitation , human fertilization , infertility , biology , chemistry , andrology , immunology , oocyte , microbiology and biotechnology , medicine , genetics , embryo , pregnancy
Immune reactions against gametes appear to be physiologically important for the maintenance of homeostasis in reproduction. In contrast, aberration of the immune homeostasis might give rise to 'immunological infertility'. Antisperm antibodies cause infertility by blocking fertilization. The mechanism can be explained as inhibiting the acrosome reaction of sperm by their blocking effect on capacitation through inhibiting an increase of fluidity of the sperm membrane. Autoantibodies against zona pellucida also cause infertility by blocking sperm-zona pellucida interaction, though the definitive mechanism has not been elucidated. Pretreatment of spermatozoa with D-mannnose completely inhibited sperm penetration through, but not binding to, the zona pellucida. Furthermore, very rapid kinetics between sperm extracts and D-mannnose by a BIAcore apparatus suggest that a D-mannose ligand of the sperm surface is easy to bind to and dissociate from a D-mannose residue in the sperm receptor site on the zona pellucida. Thus, D-mannnose on the human zona pellucida might be an essential molecule acting as a second sperm receptor, through which sperm penetrate into the zona pellucida. Because these antibodies appear to not cause any deleterious clinical symptoms, sperm and zona pellucida antigens are promising candidates in the development of an immunocontraceptive. (Reprod Med Biol 2006; 5 : 95-104).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here